Broccoli Powder for Exercise Recovery: What a Small Trial Found

Absorbed sulforaphane, no recovery benefit

Broccoli powder did what it was supposed to do at the first step: participants absorbed sulforaphane. It did not, however, improve oxidative-stress markers, lactate handling, cycling output, or jump recovery after hard exercise. For healthy, trained young men, that is the result that matters.

In a 2026 double-blind, placebo-controlled crossover trial by Cesanelli et al., 17 healthy males took 10 doses of broccoli powder over two weeks before completing a maximal progressive cycling session. Each participant also completed the control condition, using spinach powder as the comparator. That crossover design is a real advantage in a small nutrition study: each man effectively served as his own control, which reduces the noise created by differences in training status, diet, and biology between people.

The broccoli condition significantly increased urinary sulforaphane output after supplementation (p<0.05). Yet plasma malondialdehyde (MDA), a marker of lipid peroxidation, did not differ from the control condition. Neither did blood-lactate dynamics, maximal cycling power, or countermovement-jump recovery; all were non-significant. The study did not report confidence intervals for these outcomes in the available summary, so it cannot tell us how large a small benefit or harm might still be. It can tell us that this two-week broccoli-powder protocol produced no detectable performance or acute-recovery advantage in this group.

The lactate result deserves more attention than it usually gets in supplement talk. Athletes buy recovery products for outcomes they can feel or measure: less metabolic strain, better output, a quicker return of explosive function. This trial found no signal on those fronts. Sulforaphane reached the body; the hoped-for exercise benefit did not appear.

Why the biology still makes sense

Sulforaphane has a plausible mechanism. It can activate Nrf2, a transcription factor involved in cellular defense systems, including pathways that regulate antioxidant enzymes. But a plausible mechanism is a starting hypothesis, not a podium finish.

Exercise itself generates reactive oxygen and nitrogen species. Those molecules can cause damage when the burden is excessive, but they also help trigger training adaptations. Roberts et al., in a trial of an olive-derived phytocomplex in healthy adults, describe exercise-related redox signaling through Nrf2, SIRT1, and PGC-1α. The implication is not that all antioxidant supplements sabotage training. It is that suppressing every oxidative signal would be a strange goal when some of that signal tells muscle cells to adapt.

That framework makes the null MDA result hard to interpret. Broccoli powder may have failed to change lipid peroxidation. Or the cycling protocol in these trained men may not have produced a large, measurable MDA rise for any supplement to reduce. The trial cannot separate those explanations because it did not measure downstream Nrf2 activity, glutathione status, NQO1, HO-1, or glutathione-S-transferase activity.

Older adults are a different question

The strongest reason not to dismiss sulforaphane altogether comes from a different population. Rodriguez et al. reported that sulforaphane supplementation combined with exercise improved Nrf2 signaling in older adults, using in vivo measurements and ex vivo cellular assays. That finding supports the idea that the sulforaphane-exercise-Nrf2 pathway is accessible in humans.

It does not validate broccoli powder for young, trained athletes. Aging can reduce baseline Nrf2 pathway function, while fit younger people already mount a strong exercise-induced response. If one group begins with less pathway activity, it may have more room to respond. The studies also assessed different populations and endpoints: Rodriguez et al. measured Nrf2 signaling in older adults; Cesanelli et al. measured urinary sulforaphane, MDA, lactate, cycling power, and jump recovery in healthy males. Those findings can coexist without contradiction.

For adults over 50, the Rodriguez study offers a mechanistic rationale worth studying further. It does not establish that a particular broccoli-powder product improves recovery, performance, or long-term health. Those are separate claims and require trials that measure them.

Other antioxidants do not settle the sulforaphane question

The broader exercise literature is mixed because "antioxidant" is a category, not a single intervention. A 2025 systematic review and meta-analysis by Chen et al. found heterogeneous effects across antioxidant compounds, doses, supplementation periods, and exercise models. A positive result for CoQ10, curcumin, melatonin, or omega-3-rich krill oil cannot be transferred wholesale to sulforaphane.

For example, a 2024 CoQ10 meta-analysis pooled 28 randomized trials with 830 participants and reported lower creatine kinase by 50.64 IU/L (95% confidence interval, -74.75 to -26.53) and lower lactate dehydrogenase by 52.10 IU/L (95% confidence interval, -74.01 to -30.19). Those are biomarker findings for another compound, not evidence that broccoli powder works. They do show that some interventions can affect exercise-related markers under some conditions.

Baseline oxidative burden may also matter. In a crossover trial in 23 people with obesity, Ben Dhia et al. found that 3 mg melatonin reduced inflammation, oxidative stress, and muscle-damage markers after high-intensity interval exercise. People with obesity can have a greater oxidative and inflammatory response to strenuous exercise than healthy trained men. A supplement effect in that setting may reflect a larger biological problem to modify, not a universal recovery rule.

Likewise, a 2022 meta-analysis of root-plant supplements found lower indirect muscle-damage markers and soreness at 24 and 48 hours after muscle-damaging exercise. Its interventions included curcumin, ginseng, ginger, and garlic. Different compounds, different exercise models, and different endpoints mean the comparison provides context, not a substitute for a sulforaphane trial.

What limits the broccoli-powder trial

The study is useful precisely because it tested absorption and several practical outcomes, but its limits are substantial. Seventeen participants is too few to rule out modest effects, and all were male. No evidence from this trial tells us whether women would respond differently. Female hormonal physiology could matter for Nrf2-related biology, but the exercise-sulforaphane question remains untested in women.

Two weeks and 10 doses may also be too short to test a sustained Nrf2-mediated increase in endogenous antioxidant defenses. Commercial broccoli powder can lose myrosinase during processing, which may reduce conversion of glucoraphanin to sulforaphane. Higher urinary sulforaphane confirms that some conversion and absorption occurred, likely including conversion by gut microbes. It does not establish that the preparation delivered the same active exposure as fresh broccoli sprouts with active myrosinase.

The choice of placebo adds another complication. Spinach is not chemically blank; it contains nitrates, lutein, zeaxanthin, and other bioactive compounds. Any activity from the control could narrow the difference between conditions. MDA is also a relatively nonspecific oxidative-stress marker with considerable within-person variation. Measures such as F2-isoprostanes, 8-OHdG, protein carbonyls, or a glutathione redox ratio could provide a more informative test.

The practical verdict

Healthy, trained young adults should not buy broccoli powder expecting better lactate recovery, cycling performance, jump recovery, or lower acute oxidative stress after exercise. The only direct randomized crossover trial found none of those benefits despite evidence of sulforaphane absorption.

That is not proof that sulforaphane never helps anyone. It is a narrow, credible negative result: two weeks of this broccoli-powder approach did not move the measured outcomes in 17 healthy males. A more decisive trial would include at least 60 participants of both sexes, use a standardized myrosinase-active preparation for four to eight weeks, apply an exercise protocol likely to create measurable oxidative stress, and measure both sensitive oxidative biomarkers and direct Nrf2-pathway endpoints. Until then, broccoli powder remains unproven as an exercise-recovery supplement in this population.